Colin Sandercock
2019
In 2019, Colin Sandercock earned a total compensation of $625.5K as Senior Vice President, General Counsel and Secretary at Cue Biopharma, a 89% increase compared to previous year.
Compensation breakdown
| Bonus | $95,760 |
|---|---|
| Option Awards | $244,090 |
| Salary | $285,000 |
| Other | $664 |
| Total | $625,514 |
Sandercock received $285K in salary, accounting for 46% of the total pay in 2019.
Sandercock also received $95.8K in bonus, $244.1K in option awards and $664 in other compensation.
Rankings
In 2019, Colin Sandercock's compensation ranked 11,078th out of 13,971 executives tracked by ExecPay. In other words, Sandercock earned more than 20.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,078 out of 13,971 | 21st |
Division Manufacturing | 4,487 out of 5,701 | 21st |
Major group Chemicals And Allied Products | 1,759 out of 2,200 | 20th |
Industry group Drugs | 1,513 out of 1,886 | 20th |
Industry Pharmaceutical Preparations | 1,121 out of 1,398 | 20th |
Source: SEC filing on May 29, 2020.
Sandercock's colleagues
We found three more compensation records of executives who worked with Colin Sandercock at Cue Biopharma in 2019.